Quick Answer
Apimeds Pharmaceuticals US, Inc. reported Shares Outstanding of 7.90 million shares for fiscal year 2024.
Apimeds Pharmaceuticals US, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 7.90M | +0.0% |
| 2023 | 7.90M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 12.58M | — | +0.0% |
| June 30, 2025 | 12.58M | — | +59.1% |
| March 31, 2025 | 7.90M | — | +790384900.0% |
| January 31, 2025 | 1 | — | -100.0% |
| December 31, 2024 | 7.90M | — | — |
- Apimeds Pharmaceuticals US, Inc. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2023–2024 period, Apimeds Pharmaceuticals US, Inc.’s shares outstanding has grown by 0.0% (from 7.90 million shares to 7.90 million shares).
- The most recent figure is from Apimeds Pharmaceuticals US, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: